Up and down the ladder: The latest comings and goings

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going.

And here is our regular feature in which we highlight a different person each week. This time around, we note that Exscientia hired Garry Pairaudeau as chief technology officer. Previously, he worked at AstraZeneca (AZN) as vice president of hit discovery.

Pfizer (PFE) named Lindsey Dietschi as cluster lead for the Gulf region in its emerging markets unit;


Takeda Pharmaceuticals (TAK) named Ebru Yavuz as chief executive officer of its Ukraine and CIS cluster;

CVS Health (CVS) named Daniel Finke as executive vice president, and president, health care benefits segment;


Novavax (NVAX) hired Gregory Covino as executive vice president and chief financial officer;

Novavax named John Trizzino as chief commercial officer and chief business officer;

Novavax promoted Filip Dubovsky to executive vice president, chief medical officer;

Novavax promoted Beigie Lee to senior vice president, chief information officer;

Real Endpoints hired Robert O’Brien as vice president, specialty;

ObsEva (OBSV) hired Brian O’Callaghan to succeed Ernest Loumaye as chief executive officer;

Magenta Therapeutics (MGTA) hired Steve Mahoney as chief financial and operating officer;

Cytocom hired Taunia Markvicka as chief operating officer;

Sensyne Health hired Derek Baird as president, North America;

Oxeltis promoted Stephane Salamone to director of chemistry;

Inozyme Pharma (INZY) hired Kevin Johnson as senior vice president, regulatory affairs;

Pharming Group hired Jeroen Wakkerman as chief financial officer;

Korro Bio hired Ram Aiyar as chief executive officer;

Apaxen hired Bart Wuurman as chief executive officer;

Chinook Therapeutics (KDNY) hired Eric Bjerkholt as chief financial officer;

Foghorn Therapeutics hired Michael LaCascia as chief legal officer;

Apnimed hired Michael Rogers as chief financial officer;

Aequus Pharmaceuticals (AQSZF) says Anne Stevens is stepping down as chief operating officer;

Kira Pharmaceuticals hired Frederick Beddingfield as chief executive officer;

Silverback Therapeutics hired Jonathan Piazza as chief financial officer;

Talis Biomedical hired Rob Kelley as chief commercial officer;

Talis Biomedical hired Douglas Liu as senior vice president, operations;

Talaris Therapeutics hired Michael Zdanowski as chief technology officer;

Talaris Therapeutics hired Farah Natoli as head of portfolio and program management;

Talaris Therapeutics hired Mary West as vice president, clinical operations;

Graphite Bio Katherine Vega Stultz as chief operating officer;

Graphite Bio hired Philip Gutry as chief business officer and head of finance and investor relations.

Source: STAT